Lv2
136 积分 2025-07-08 加入
Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study
12天前
已完结
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
18天前
已完结
CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome
1个月前
已完结
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)
1个月前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
1个月前
已完结
[Expert consensus on the management practice of CD19 CAR-T cell therapy for B-cell lymphoma in China (2025 edition)]
2个月前
已完结
A daily multivitamin slows the ticking of epigenetic clocks
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
2个月前
已完结
Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian Cancer Therapy
2个月前
已完结
Re-imagining human cell culture media: Challenges, innovations, and future directions
3个月前
已完结
皖公网安备34019202002308
